
This new mRNA vaccine could better protect against the flu
The U.S.-approved vaccine – faster to produce and more precise than traditional flu shots – is awaiting the green light in Canada
We use Google Analytics to see which stories get read. It’s always on because it’s how we learn what readers want more of, and it doesn’t use advertising cookies. Third-party tracking for advertising is optional and stays off unless you accept it. Learn more.
Andrea Yu is a Toronto-based freelance journalist. She regularly contributes to the Globe and Mail, Toronto Life and Chatelaine, covering a range of topics from business to real estate, women's health, travel, design, employment and food.

The U.S.-approved vaccine – faster to produce and more precise than traditional flu shots – is awaiting the green light in Canada

Indigenous entrepreneurs over-index on scale and ambition, according to Be Giant's data

The U.S.-approved vaccine – faster to produce and more precise than traditional flu shots – is awaiting the green light in Canada

Indigenous entrepreneurs over-index on scale and ambition, according to Be Giant's data

The U.S.-approved vaccine – faster to produce and more precise than traditional flu shots – is awaiting the green light in Canada

Indigenous entrepreneurs over-index on scale and ambition, according to Be Giant's data